Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 208798
Company: TEVA PHARM
Company: TEVA PHARM
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ARMONAIR DIGIHALER | FLUTICASONE PROPIONATE | 0.055MG/INH | POWDER;INHALATION | Prescription | None | Yes | No |
ARMONAIR DIGIHALER | FLUTICASONE PROPIONATE | 0.113MG/INH | POWDER;INHALATION | Prescription | None | Yes | No |
ARMONAIR DIGIHALER | FLUTICASONE PROPIONATE | 0.232MG/INH | POWDER;INHALATION | Prescription | None | Yes | Yes |
ARMONAIR DIGIHALER | FLUTICASONE PROPIONATE | 0.03MG/INH | POWDER;INHALATION | Discontinued | None | Yes | No |
ARMONAIR RESPICLICK | FLUTICASONE PROPIONATE | 0.055MG/INH | POWDER;INHALATION | Discontinued | None | Yes | No |
ARMONAIR RESPICLICK | FLUTICASONE PROPIONATE | 0.113MG/INH | POWDER;INHALATION | Discontinued | None | Yes | No |
ARMONAIR RESPICLICK | FLUTICASONE PROPIONATE | 0.232MG/INH | POWDER;INHALATION | Discontinued | None | Yes | No |
ARMONAIR RESPICLICK | FLUTICASONE PROPIONATE | 0.03MG/INH | POWDER;INHALATION | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/27/2017 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208798s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208798Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208798Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
11/16/2023 | SUPPL-16 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208798Orig1s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208798Orig1s016ltr.pdf | |
04/08/2022 | SUPPL-13 | Manufacturing (CMC)-New Strength |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208798s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/208798Orig1s013ltr.pdf | |
01/27/2022 | SUPPL-10 | Labeling-Container/Carton Labels |
Label is not available on this site. |
||
07/09/2021 | SUPPL-8 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208798s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208798Orig1s008ltr.pdf | |
09/18/2020 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208798s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208798Orig1s007ltr.pdf | |
03/02/2018 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208798s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208798Orig1s002,208799Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
11/16/2023 | SUPPL-16 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208798Orig1s016lbl.pdf | |
04/08/2022 | SUPPL-13 | Manufacturing (CMC)-New Strength | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208798s013lbl.pdf | |
07/09/2021 | SUPPL-8 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208798s008lbl.pdf | |
09/18/2020 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208798s007lbl.pdf | |
03/02/2018 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208798s002lbl.pdf | |
01/27/2017 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208798s000lbl.pdf |